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Abstract
Background: Prolonged elevated levels of lipids have negative effects on beta-cell function and mass (lipotoxicity).
To what extent exposure to high glucose concentration is important in the harmful effects of lipids
(glucolipotoxicity) has been debated.
Methods: We addressed beta-cell lipotoxicity by measuring apoptosis in isolated intact control human islets and
insulin-secreting cell lines MIN6 and INS-1E cultured in the presence of palmitate and low (5.5 mM) or high
(25 mM) glucose for 48 hours.
Results: In both cell lines and human islets palmitate induced apoptosis after culture at low glucose. Palmitate-
induced apoptosis was not increased after culture at high compared to low glucose in human islets and MIN6 cells
but glucose-induced rise in apoptosis was observed in INS-1E cells. The rise in apoptosis in INS-1E cells was
partially reversed by inclusion of AMPK-agonist AICAR. When CPT1-inhibitor etomoxir was included during culture
at low glucose palmitate-triggered apoptosis was accentuated both in the islets and the cell lines. Palmitate
oxidation in human islets and the cell lines was comparable after culture at low glucose. At high glucose, palmitate
oxidation was reduced by 30% in human islets and MIN6 cells but by 80% in INS-1E cells. In INS-1E cells, AICAR
increased oxidation of palmitate. Presence of etomoxir at low glucose decreased palmitate oxidation both in the
islets and the cell lines.
Conclusions: In summary, lipotoxicity is evident not only in the presence of high but also low glucose
concentrations. Additional effects of glucose are prominent in INS-1E but not in MIN6 cells and intact control
human islets, which are able to efficiently oxidize fatty acids at high glucose and in this way avoid
glucolipotoxicity.
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Introduction
Elevated blood glucose and lipid levels are manifesta-
tions of individuals with type 2 diabetes mellitus [1-4].
Insulin-secreting beta-cells in these individuals are char-
acterized by impaired glucose-stimulated insulin secre-
tion (GSIS) and enhanced apoptosis [5]. Several
mechanisms of such toxicity have been proposed includ-
ing ceramide formation [6], increased oxidative stress [7]
and activation of ER stress [8]. However, it remains
debated whether elevated fatty acids may impair beta-
cell function and cause apoptosis at normal glucose con-
centrations (lipotoxicity) or only in combination with
elevated glucose levels (glucolipotoxicity). It has been
suggested that hyperlipidemia alone is not detrimental
for beta-cells [9,10]. Hyperglycemia was proposed to be
a prerequisite for fatty acid induced beta-cell dysfunc-
tion and death. Beta-cells exposed to combined high
levels of glucose and fatty acids preferentially metabolize
glucose [11] and direct long chain (LC)-CoA towards
toxic non-oxidative metabolic pathways [12,13]. Lipid
oxidation is inhibited by elevated levels of glucose-
derived malonyl-CoA, which regulate lipid partitioning
through its inhibitory action on mitochondrial fatty acid
transporter carnitine palmitoyltransferase-1 (CPT-1)
[14]. Consistent with these ideas it was shown that
AICAR and metformin, agents that favor fatty acid
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agent that inhibits b-oxidation, exerts opposite effects
[11,15].
Analysis of studies performed on intact human islets
indicates that fatty acids exert their toxic effect inde-
pendently of glucose concentration [6,16,17]. Also, in
vivo studies showed that sustained increase in plasma
free fatty acids impairs insulin secretion in non-dia-
betic subjects genetically predisposed to develop
T2DM [18].
In the present study we have addressed beta-cell lipo-
toxicity by measuring how glucose affects palmitate-
induced apoptosis in isolated human islets and insulin-
producing cell lines INS-1E and MIN6. Palmitate is an
abundant fatty acid present in the circulation and parti-
cularly linked with development of beta-cell dysfunction
[19,20]. Based on the malonyl-CoA long-chain hypoth-
esis [14] we evaluated to what extent high glucose levels
inhibited lipid oxidation as a mechanism of beta-cell
glucolipotoxicity. The results indicate that palmitate
provokes its negative effect even at low glucose. High
glucose accentuates palmitate-induced apoptosis in INS-
1E cells but not in human islets and in MIN6 cells. We
propose that this is due to limited glucose-induced inhi-
bition of fatty acid oxidation in human islets and MIN6
cells.
Materials and methods
Cell culture
Rat INS-1E cells (a kind gift from Dr. Pierre Maechler,
Geneva University) were cultivated in RPMI 1640 med-
ium containing 11 mM glucose and supplemented with
10% fetal bovine serum (FBS), 2 mM L-glutamine, 1
mM sodium pyruvate, 10 mM HEPES and 55 μM b-
mercaptoethanol at 37°C and 5% CO2. All reagents were
purchased from Invitrogen (Carlsbad, CA). Experiments
with INS-1E cells were performed between passages 65
and 90. Mouse insulinoma MIN6 cells (a kind gift from
Prof. Jun-Ichi Miyazaki, Osaka University) were main-
tained in Dulbecco’s Modified Eagle medium (DMEM)
containing 25 mM glucose and supplemented with 10%
FBS and 55 μM b-mercaptoethanol at 37°C and 5%
CO2. All experiments with MIN6 cells were performed
between passages 21 and 28. Human islets were
obtained from the Islet Transplantation Unit at Uppsala
University from non-diabetic individuals. Human islets
were cultured in CMRL 1066 medium containing 5.5
mM glucose and supplemented with 10% FBS.
Ethics Statement
Ethical permission to use human islets isolated from
healthy individuals have been obtained from the Regio-
nal Ethical Review Board in Uppsala (date: 2010-02-10;
number 2010/006).
Free fatty acid preparation and cell/islet treatment
Culture medium containing palmitate (Sigma, St. Louis,
MO) was prepared as previously described [8,21].
Briefly, the fatty acid was dissolved in 50% ethanol to a
concentration of 100 mM. This stock solution was
diluted in culture medium to a required concentration
and then allowed to complex with 0.5% fatty acid free
BSA (Boehringer Mannheim GmbH, Mannheim, Ger-
many) for 30 min at 37°C. Cells cultured to 65-70% con-
fluence or ~50 human islets were exposed to palmitate
in the presence of different concentrations of glucose
for 48 hours. Whereas FBS was maintained during pal-
mitate exposure of INS-1E and MIN6 cells [8,22], FBS
was removed during palmitate incubation of human
islets [16]. Cells and islets cultured in the presence of
palmitate were also treated with 1 mM AICAR or 0.2
mM etomoxir (both purchased from Sigma).
Measurements of palmitate oxidation rate and
accumulation
Cells/islets were cultured in media containing 0.5 mM
palmitate and 2 μCi [
3H]palmitate per ml. After culture,
media samples were collected and
3H2O separated from
[
3H]palmitate using Folch extraction [23]. To measure
accumulation, cells and islets were lysed using H2O.
T h ev o l u m eo f1 0m lU l t i m aG o l d ™ scintillation fluid
(Chemical Instruments AB, Sollentuna, Sweden) was
added to 500 μl
3H2O and radioactivity determined by a
liquid-scintillation spectrometer (Wallac System 1400™
PerkinElmer, Boston, MA). The results were normalized
to DNA content.
Measurements of metabolic activity
Metabolic activity was determined by MTT (Sigma
Aldrich) assay, which measures NAD(P)H production
through glycolysis [24]. MTT solution was prepared as 5
mg/ml stock in PBS just before use. After culture, 50 μl
of MTT solution was added to each well. After 4 hours
incubation, medium containing MTT was removed and
500 μl of DMSO added to the cells. The spectrophoto-
metric absorbance was then measured at 540 nm. The
results were normalized to DNA content.
Protein measurements by Western blot analysis
Cells/islets were washed twice with PBS and then lysed
in 1% Triton X100 in PBS containing protease inhibitor
mixture (Sigma) for 30 min. After lysis, cells were
scraped and centrifuged at 12,000 rpm for 10 min.
Ensuing supernatant was collected, and total protein
concentration was determined by the DC protein assay
(Bio-Rad, Hercules, CA) according to the manufacturer’s
instruction. Equal amounts of protein were solubilized
by SDS-PAGE sample buffer, boiled for 5 min, resolved
by SDS-PAGE and transferred to PVDF membrane.
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towards cleaved form of caspase 3, phosphorylated
acetyl-CoA carboxylase (p-ACC), ACC and fatty acid
synthase (FAS) (all from Cell Signaling, Beverly, MA).
Immunoreactive bands were visualized with Fluor-S
MultiImager MAX (Bio-Rad) and quantified with Quan-
tity One software (Bio-Rad). To normalize the expres-
sion level of each protein, PVDF membranes were
stained with Coomassie, scanned and quantified with
the Quantity One software.
Apoptosis measurements by DNA fragmentation analysis
Fragmentation of DNA in cells/islets was assayed with
the cell death detection kit ELISA
PLUS (Roche Diagnos-
tics, Mannheim, Germany) according to the manufac-
turer’s instructions. Twenty islets of comparable size
were used for measurements [6]. The ELISA measures
cytoplasmic oligonucleosomes that increase after apop-
tosis-associated DNA degradation. The measurements
were related to DNA content.
Data analysis
Results are presented as means ± SEM. Statistical signif-
icance between two conditions was analyzed using one-
w a yA N O V Aw i t hT u k e yp o s t - h o ct e s t .P <0 . 0 5w a s
considered statistically significant.
Results
Palmitate-induced apoptosis is accentuated by high
glucose in INS-1E cells but not in human islets and MIN6
cells
Apoptosis was measured after culturing INS-1E and
MIN6 cells and human islets in the presence of 0.25, 0.5
and 1 mM palmitate for 24 and 48 hours. Elevated levels
of apoptosis were observed in the cell lines and human
islets, when the ambient palmitate concentration was 0.5
mM or higher and the culture time was 24 hours (Fig-
ure 1A) or 48 hours (Figure 1B). Palmitate-induced
apoptosis was more accentuated in INS-1E cells com-
pared to MIN6 and human islets. We next examined to
what extent the glucose concentration affected palmi-
tate-induced apoptosis. Whereas DNA fragmentation
was 8-fold and expression of active caspase 4-fold in
palmitate-treated INS-1E cells exposed to high (25 mM)
glucose compared to control cells, these parameters
were changed only ~2-fold in INS-1E cells exposed to
low (5.5 mM) glucose (Figure 2). Apoptosis was 2-fold
increased in MIN6 cells and 1.5-fold in human islets
irrespective of glucose concentrations i.e. no differences
in apoptosis were observed when palmitate-exposed
MIN6 cells and human islets were cultured at low or
high glucose. To elaborate the role of fatty acid oxida-
tion, AICAR and etomoxir were used. When AICAR
was added to cells exposed to palmitate and high
glucose, DNA fragmentation and caspase 3 levels
observed in INS-1E cells were lowered compared to pal-
mitate treatment alone. AICAR-treatment did not affect
apoptosis in human islet or MIN6 cells, however. When
etomoxir was added to cells exposed to palmitate and
low glucose ~1.5-fold rise in the levels of DNA fragmen-
tation and cleaved caspase 3 was observed in the cell
lines and islets compared to palmitate treatment alone.
Palmitate oxidation is substantially reduced by high
glucose in INS-1E cells but only moderately in human
islets and MIN6 cells
The glucose-dependency in INS-1E cells and glucose-
independency in human islets and MIN6 cells of palmi-
tate-induced apoptosis (Figure 2) was hypothesized to
depend on differences in oxidation of the fatty acid. Pal-
mitate oxidation was therefore measured in palmitate-
exposed INS-1E and MIN6 cells and human islets cul-
tured at high or low glucose for 48 hours. In INS-1E
cells exposed to palmitate oxidation rate of the fatty
acid was reduced by 80% in cells cultured at high
Figure 1 Apoptosis in palmitate-exposed INS-1E cells (white
bars), MIN6 cells (grey bars) and human islets (black bars)
measured as DNA fragmentation. The cells and islets were
cultured for 24 (A) and 48 (B) hours in the presence of 0.25, 0.5 and
1 mM palmitate. INS-1E cells cultured at 11 mM glucose, MIN6 cells
at 25 mM glucose and human islets at 5.5 mM glucose alone were
considered as controls. Results are means ± SEM of 3-4
independent experiments. *P < 0.05 compared to controls.
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ure 3A). Glucose-dependent palmitate oxidation was
also seen in MIN6 cells and human islets although to a
much less extent. In human islets and MIN6 cells cul-
tured at high glucose palmitate oxidation was lowered
by about 30% compared to islets and cells cultured at
low glucose. Next, we compared oxidation rates of pal-
mitate in palmitate-exposed INS-1E cells, MIN6 cells
and human islets after 48 hours. At high glucose
human islets oxidized the fatty acid two times more
than MIN6 cells and four times more than INS-1E
cells (Figure 3A). In contrast, no significant difference
in palmitate oxidation was observed between palmi-
tate-exposed human islets, MIN6 and INS-1E cells cul-
tured at low glucose. Addition of AICAR restored the
glucose-dependent reduction in palmitate oxidation
partially in INS-1E cells but not in MIN6 cells and
human islets (Figure 3A). When etomoxir was added
palmitate oxidation was reduced both in cell lines and
islets. The reduction was especially pronounced in
human islets (Figure 3A). Measurements of palmitate
accumulation were in agreement with oxidation data.
Higher oxidation rate of palmitate was accompanied by
lower accumulation of palmitate inside the cells/islets
(Figure 3B). To exclude the possibility that the pro-
nounced glucose-induced difference in palmitate oxida-
tion observed in INS-1E cells was due to changes in
metabolic activity we measured mitochondrial activity
in these cells after 48 hours culture in the presence of
palmitate and normalized it to DNA content. As
expected, activity was reduced by etomoxir and
induced by AICAR but was not altered by changing
the glucose concentration (Figure 4).
Figure 2 Apoptosis in palmitate-exposed INS-1E cells (white
bars), MIN6 cells (grey bars) and human islets (black bars)
measured as DNA fragmentation (top panel) and cleaved
caspase 3 (bottom panel). The cells and islets were cultured for 48
hours in the presence of 0.5 mM palmitate at indicated glucose
(Glu) concentrations. AICAR (1 mM; Aic) and etomoxir (0.2 mM; Et)
were added as indicated. INS-1E cells cultured at 11 mM glucose,
MIN6 cells at 25 mM glucose and human islets at 5.5 mM glucose
alone were considered as controls. Results are means ± SEM of 4-6
independent experiments. *P < 0.05 compared to low glucose and
#p < 0.05 effect of additive.
Figure 3 Palmitate oxidation (A) and accumulation (B) in
palmitate-exposed INS-1E cells (white bars), MIN6 cells (grey
bars) and human islets (black bars). The cells and islets were
cultured for 48 hours in the presence of 0.5 mM palmitate and 2
μCi [
3H]palmitate per ml at indicated glucose (Glu) concentrations.
AICAR (1 mM; Aic) and etomoxir (0.2 mM; Et) were added as
indicated. After culture, media were collected,
3H2O separated and
radioactivity determined by a liquid-scintillation spectrometer. To
measure palmitate accumulation, radioactivity was determined in
lysed cells and islets. Results are means ± SEM of 3-4 independent
experiments. *P < 0.05 compared to low glucose and #p < 0.05
effect of additive.
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INS-1E cells but only moderately in human islets and
MIN6 cells
Oxidation rate of palmitate is regulated by malonyl-CoA,
which inhibits CPT1 and prevents translocation of fatty
acids into the mitochondria. The cellular pool of malonyl-
CoA is determined by opposing activities of ACC and
FAS. To address the role of malonyl-CoA in glucose-regu-
lated oxidation of palmitate expression levels of p-ACC,
ACC and FAS were measured in INS-1E cells, MIN6 cells
and human islets exposed to palmitate in the presence of
5.5 and 25 mM glucose. In INS-1E cells p-ACC/ACC was
reduced by 70% at high glucose compared to low glucose
indicating higher activity of ACC and higher production of
malonyl-CoA in the presence of high glucose (Figure 5A).
In MIN6 cells and human islets the ratio was only reduced
by 20-30% at high glucose compared to low glucose.
When FAS was examined in cells and islets no significant
difference was observed when compared with effects of
palmitate at high and low glucose (Figure 5B).
Discussion
Augmented blood lipid and glucose levels are character-
istics of type 2 diabetes mellitus [1,2]. The simulta-
neously elevated levels of nutrients have been proposed
to play a key role in the development of beta-cell toxi-
city manifested by impaired GSIS and reduced mass
[9,10]. In the present study beta-cell lipotoxicity was
evaluated by measuring beta-cell apoptosis. We demon-
strated that palmitate has a toxic effect at low glucose
concentration. Accentuation of fatty-acid induced apop-
tosis by high glucose was observed in INS-1E cells but
not in human islets and MIN6 cells.
In many studies addressing beta-cell glucolipotoxicity
insulin-producing cell lines were used [14,22,25,26]. In
agreement with previous reports, enhanced apoptosis was
observed in the present study when INS-1E cells were
exposed to glucolipotoxic conditions. In contrast, no glu-
colipotoxic effect was observed in MIN6 cells and, more
importantly, in human islets. Evidence that intact human
islets do not show signs of glucolipotoxicity can also be
found in other studies [6,16,17]. In contrast, when human
islets were dispersed, enhanced palmitate-induced apopto-
sis was observed when the glucose concentration was
increased [11,25,26]. It appears that intact islet architec-
ture is protective against the combined effects of palmitate
and high glucose. Along these lines, superior performance
of the intact islet compared to dispersed islet cells has
been demonstrated with regard to insulin secretion [27].
The negative effects on the beta-cell of simultaneous
exposure to elevated levels of fatty acids and glucose
Figure 4 Metabolic activity in palmitate-exposed INS-1E cells.
Cells were cultured for 48 hours in the presence of 0.5 mM
palmitate at indicated glucose (Glu) concentrations. AICAR (1 mM;
Aic) and etomoxir (0.2 mM; Et) were added as indicated. After
culture, metabolic activity was measured using the MTT assay. INS-
1E cells cultured at 11 mM glucose alone were considered as
control. Results are means ± SEM of 3 independent experiments. *P
< 0.05 compared to control.
Figure 5 p-ACC/ACC ratio (A) and FAS expression level (B) in
palmitate-exposed INS-1E cells (white bars), MIN6 cells (grey
bars) and human islets (black bars). The islets and cells were
cultured for 48 hours in the presence of 0.5 mM palmitate at
indicated glucose (Glu) concentrations. INS-1E cells cultured at 11
mM glucose, MIN6 cells at 25 mM glucose and human islets at 5.5
mM glucose were considered as controls. After culture, protein
levels of p-ACC, ACC and FAS were measured. Results are means ±
SEM of 3-4 independent experiments. *P < 0.05 compared to
control.
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oxidation due to inhibition of CPT1 by glucose-induced
formation of malonyl-CoA [13,14]. In support of this
notion the negative effects of palmitate on beta-cell
apoptosis has been demonstrated to be accentuated if
the fatty acid is directed away from oxidative pathways
by pharmacological inhibition of CPT1 in some [11,22]
but not all [28] studies. To test the malonyl-CoA
hypothesis, etomoxir was added during culture in the
present study. Reduction of fatty acid oxidation was par-
alleled by increased apoptosis in both cells and islets,
reinforcing the role of palmitate oxidation in lipotoxi-
city. Formation of ceramide and other pro-apoptotic
lipid species has been proposed as underlying cause for
the rise in beta-cell apoptosis observed when palmitate
oxidation is reduced [6]. In this context it should be
noted that triacylglycerol (TAG) formation may repre-
sent a less harmful way for the cell to channel surplus
fatty acids [28].
The fact that FAS was not altered in the present study
may indicate that lipogenesis and the formation of TAG is
not activated in palmitate-treated beta-cells which is in
agreement with a recent paper where beta-cells exposed to
palmitate showed much lower oxidation rate and TAG
formation than cells exposed to oleate [29]. Also, FAS and
other enzymes of lipogenesis controlled by SREBP-1c are
activated much more when palmitate is replaced by oleate
[29]. At the same time, accumulation of radioactivity
inside the cell/islets indicates that palmitate is directed
towards formation of other species rather than TAG.
Whereas high glucose concentration reduced palmi-
tate oxidation to a minor extent in human islets, the
reduction was accentuated in INS-1E cells. We conclude
that human islets obtained from control donors are able
to efficiently oxidize fatty acids at high glucose and in
this way avoid glucolipotoxicity. Substantial glucose-
induced reduction in palmitate oxidation in INS cells
was also observed in a previous study [30]. The
observed difference in palmitate oxidation might be
explained by higher ACC activity in INS-1E cells com-
pared to human islets. The glucose-induced reduction in
p-ACC observed in the present study is almost identical
to the reduction in palmitate oxidation, which could be
explained by a rise in malonyl-CoA [14]. The observa-
tion that differences in glucose-induced changes in ACC
activity correspond with changes in palmitate oxidation
but not fully with changes in apoptosis illustrates the
complexity by which palmitate influences the beta-cell.
Our results also indicate that beta-cell mitochondrial
function is not affected to any major extent in the pre-
sence of palmitate during the indicated time periods
since mitochondrial activity was not changed much
when taking into account apoptotic cells/islets.
The observation that palmitate-induced apoptosis is
evident not only in the presence of high but also low
glucose concentrations underscores the importance of
not only maintaining normal blood glucose but also
lipid levels in individuals with T2DM. Also, in obese
individuals, especially the ones with a genetic back-
ground of T2DM, normalizing blood lipid levels would
be extremely important to prevent beta-cell apoptosis.
Whether the onset of diabetes and elevated glucose
levels in obese individuals accelerates beta-cell destruc-
tion is not completely clear from this study. The
enhanced palmitate-induced apoptosis at high glucose
observed in INS-1E cells but not in islets obtained from
healthy individuals and in MIN6 cells might be
explained by limited inhibition of fatty acid oxidation by
malonyl-CoA in the latter and may speak in favor of the
notion that glucolipotoxicity becomes manifest given a
genetic background predisposing to beta-cell failure.
Conclusion
We conclude that lipotoxicity is evident not only in the
presence of high but also low glucose concentrations. It
underscores the importance to not only maintaining
normal blood glucose but also lipid levels in individuals
with T2DM. Our data also suggest that healthy human
islets are able to efficiently oxidize fatty acids at high
glucose and in this way avoid glucolipotoxicity.
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